A sustainable system for decontamination of cephalexin antibiotic using electrocoagulation technology and response surface methodology

The emergence of synthetic micropollutants in wastewater due to domestic and industrial use has presented new challenges for treatment processes. Among these pollutants, pharmaceutical and personal care products (PPCPs) are considered emerging contaminants due to their potential to enter drinking water sources. Antibiotics, in particular, are of significant concern due to their high consumption in veterinary and human applications. In this study, the electrocoagulation (EC) process is used as an efficient technique for the removal of cephalexin (CFX) from pharmaceutical wastewater. The study aims to explore the ability of the EC process to remove CFX and optimize its performance using the response surface method based on Central Composite Design (RSM-CCD). The effects of initial CFX concentration, electrolysis time, initial pH, and electrode type (non-insulated and insulated) were considered in the optimization process. This research is distinct as it examines the influence of key factors on the elimination of CFX. The results showed that electrolysis time had the most significant effect on CFX removal using the EC process. The analysis of variance (ANOVA) test was used to evaluate the importance of independent variables and their interaction. The optimal operating conditions for maximum removal efficiency (86.53%) were an initial cephalexin concentration, reaction time, and initial pH of 34 mg/L, 34.35 min, and 6.5, respectively, using an insulated electrode. Under these optimal conditions, predicted cephalexin removal was 93.54%. These findings demonstrate that RSM-CCD is a useful tool for optimizing electrochemical removal processes for micropollutants such as CFX from wastewater streams. The study highlights the importance of considering electrode type in optimizing EC processes for micropollutant removal from wastewater.